期刊文献+

VEGF、组织因子及D-二聚体与肺癌关系的研究(英文)

Research on the Relationship among VEGF,Tissue Factor,D-Dimer and Lung Cancer
原文传递
导出
摘要 目的:探讨肺癌患者血浆VEGF、组织因子及D-二聚体水平与并发静脉血栓的关系及其相关性。方法:收集2013年3月至2013年9月,青岛大学附属医院收治的初诊肺癌患者83例为肺癌组,肺癌并静脉栓塞组11例,健康体检组80例,应用酶联免疫吸附(ELISA)法测定VEGF、TF、D-二聚体的水平并进行比较分析。结果:肺癌组和肺癌并静脉栓塞组血浆VEGF、TF及D-二聚体水平均高于健康对照组,肺癌并静脉栓塞组血浆VEGF、TF及D-二聚体水平高于肺癌组,VEGF与TF及D-二聚体的表达呈正相关。结论:VEGF、TF及D-二聚体是肺癌患者并发静脉血栓的重要标志物,可通过测定其在肺癌患者血浆中的水平来推测并发静脉血栓的危险性,以针对性应用抗凝治疗。 Objective: To investigate the relationship among boold levels of vascular endothelial growth factor (VEGF), tissue factor (TF), D-Dimer and thromboembolic events in patients with lung cancer. Methods: From March to September 2013, 83 cases of the first diagnosis lung cancer patients of the affiliated hospital of Qingdao University were collected as lung cancer group, 11 lung cancer patients accompanied with venous thromboembolism (VTE) as lung cancer with VTE group and 80 normal healthy as controls. VEGF, TF and D-Dimer levels in serum were detected by enzyme-linked immunosorbent assay (ELISA). The correlation among VEGF, TF, D-Dimer and lung cancer was analyzed. Results: VEGF, TF and D-Dimer levels in serum of lung cancer group and lung cancer with VTE group were significantly higher than that in normal control group (P〈0.05). VEGF, TF and D-Dimer levels of lung cancer with VTE group were observably higher than that in lung cancer group (P 〈0.05). The expression of VEGF and TF and D-Dimer was positively correlation in lung cancer with VTE patients. Conclusions: VEGF, TF and D-Dimer are important marks of lung cancer patients accompanied with thromboembolism events. The risk of venous thrombosis of lung cancer patients can be evaluated by measuring the levels ofVEGF, TF and D-Dimer, in order to applicate anticoagulant therapy pertinently.
出处 《现代生物医学进展》 CAS 2014年第20期3888-3890,共3页 Progress in Modern Biomedicine
基金 Qingdao Municipal Science and Technology Bureau funded projects(09-2-2-3-msh-5)~~
关键词 肺癌 VEGF TF D-二聚体 静脉血栓 Lung cancer VEGF TF D-Dimer VTE
  • 相关文献

参考文献22

  • 1Blom Jw, Osanto S, Rosendaa Fr. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than sq- uamous cell carcinoma[J]. J Thromb Haemost, 2004, 2(10): 1760-1 765.
  • 2Rybicki Fj, Prevedello Lm, Di Salvo Dn, et al. Imaging presentation of venous thrombosis in patients with cancer [J]. A JR Am J Roentgenol, 2010, 194(4): 1099-1108.
  • 3Prandoni P, Piccioli A. Venous thromboembolism and cancer: a two-way clinical association[J]. Front Biosci, 1997, 2: e 12 -e20.
  • 4Carrier M, Le Gal G, Wells Ps, et al. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism[J]. Annals of Internal Medicine, 2008, 149(5): 323.
  • 5Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembo- lism and its effect on survival among patients with common cancers [J]. Arch Intern Med, 2006, 166:458-464.
  • 6G6 mez-Outes A, Sudl rez-Gea ML, Lecumberri R, et al. Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients[J]. Vascular Health and Risk Ma- nagement, 2013, 9:207-228.
  • 7Nichols L, Sannders R, KnoUmarm FD. Causes of death of patients with lung cancer[J]. Arch Pathol Lab Med, 2012, 136(12): 1552-1557.
  • 8Inn Zachary, Georgia Glik, Signaling transduction mechanisms mediat- e-Ng biological actions of the vascular endothelia growth factor family [J]. Cardiovascular Research, 2001, 49:586-581.
  • 9Caeciola RR, di Franeeso ED, Caeciola E, et al. Elevated serum vascular endothelial growth factor levels in patients with polycythemi- a vera and thrombotic complications [J]. Haematologica, 2002, 87(7): 774-775.
  • 10Kirwan CC, Byrne G J, Kumar S, McDowell G. Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer[J]. J Angiogenes Res, 2009, 1(7): 1-9.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部